Changes in HbA1c, body weight, and systolic blood pressure in type 2 diabetes patients initiating dapagliflozin therapy: a primary care database study
Markus F Scheerer,1 Roland Rist,1 Orm Proske,1 Annika Meng,2 Karel Kostev2 1Medical Department, AstraZeneca GmbH, Wedel, Germany; 2IMS Health GmbH & Co. OHG, Frankfurt am Main, Germany Aims: To investigate changes in glycated hemoglobin (HbA1c), body weight (BW), and systolic blood pressure...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2016
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/6bdf6365d9f54615ae1a3f8dbfbe6b05 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|